Table 3 Multivariate analysis at >9- and >12-month time points (gender and hep C status are adjusted for age as a group variable)
From: Retention in Georgia opioid substitution therapy program and associated factors
Model I: program specific | Model II: being on OST | |||
|---|---|---|---|---|
OR 95% CI | P values | ORs 95% CI | p values | |
9 months | ||||
Age (>40 vs. ≤40 years) | 2.05 (1.34–3.15) | <0.001 | 2.33 (1.53–3.55) | <0.001 |
Age (cont. variable) | 1.06 (1.03–1.08) | <0.001 | 1.06 (1.05–1.09) | <0.001 |
Gender (male vs. female) | 2.71 (1.06–6.95) | 0.038 | 3.18 (1.26–8.0) | 0.014 |
Hepatitis C status | 1.55 (1.01–2.37) | 0.042 | ||
12 months | ||||
Age (>40 vs. ≤40 years) | 2.36 (1.53–3.64) | <0.001 | 2.37 (1.55–3.64) | <0.001 |
Age (cont. variable) | 1.06 (1.04–1.09) | <0.001 | 1.06 (1.04–1.10) | <0.001 |
Gender (male vs. female) | 2.48 (0.95–6.48) | 0.064 | ||
Hepatitis C status | 1.58 (1.03–2.44) | 0.034 | ||